L. Kerkhofs

Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial.

C. Seynaeve, J. Verweij, A. Sparreboom, 2004, European journal of cancer.

Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer

P. Siersema, H. Tilanus, A. Gaast, 1999, British Journal of Cancer.

Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.

H. Codrington, H. Sleeboom, L. W. Wormhoudt, 2008, European journal of cancer.

Lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in Dutch patients.

J. Timmer-Bonte, L. Faber, L. Laterveer, 2020, The Netherlands journal of medicine.

Use of biosimilar epoetin to increase hemoglobin levels in patients with chemotherapy-induced anemia: real-life clinical experience.

G. Boschetti, D. Stănculeanu, A. Palomo, 2012, Future oncology.

Beneficial effects of adenosine triphosphate on nutritional status in advanced lung cancer patients: a randomized clinical trial.

P. Dagnelie, J. Wilson, H. Agteresch, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre.

C. Seynaeve, J. Verweij, M. Bontenbal, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer.

J. Verweij, H. V. van Doorn, D. ten Bokkel Huinink, 2014, European journal of cancer.

Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.

H. Codrington, H. Sleeboom, L. W. Wormhoudt, 2008, European journal of cancer.